Rest Of Asia Pacific Urology Devices Market (2025-2030)
The Rest Of Asia Pacific Urology Devices Market was valued at $2107.9 Million in 2025 and projected to reach to $2877 Million by 2030, representing a compound annual growth rate of 6.4%. The Rest Of Asia Pacific urology devices market is positioned for robust growth through 2030, supported by expanding healthcare access and rising patient awareness of urological conditions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific Urology Devices Market Trends and Insights
- Rest Of Asia Pacific demonstrates a compound annual growth rate of 6.4%, outpacing the global average and reflecting increasing healthcare investments across emerging economies in the region.
- This growth trajectory in Rest Of Asia Pacific is driven by rising prevalence of urological disorders, aging populations, and expanding access to advanced diagnostic and therapeutic devices. Rest Of Asia Pacific's market expansion is supported by improving healthcare infrastructure and growing patient awareness of urological conditions.
- The region's urology devices sector in Rest Of Asia Pacific benefits from both public and private sector initiatives to enhance medical device availability.
- Rest Of Asia Pacific is witnessing increased adoption of minimally invasive procedures and innovative treatment solutions, positioning the region as a significant growth opportunity within the broader Asia Pacific market through 2030..
Key Market Statistics
- CAGR (2025-2030) 6.4% CAGR
- Market Size, 2025 ~USD 2107.9 Million
- Forecast, 2030 ~USD 2877 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Urology Devices Market Overview
Regional Growth Outpacing Global Average :
Rest Of Asia Pacific's urology devices market is expanding at 6.4% CAGR, exceeding the global rate of 6%, driven by rising healthcare expenditures and improving medical infrastructure across emerging economies in the region.
Substantial Market Valuation Growth :
The market is valued at USD 2,107.9 million in 2025 and is projected to reach USD 2,877.0 million by 2030, representing a growth of approximately USD 769.1 million over the five-year forecast period.
Emerging Economy Healthcare Investments :
Increasing government and private sector investments in healthcare infrastructure across Rest Of Asia Pacific countries are creating favorable conditions for urology device adoption and market penetration.
Rising Prevalence of Urological Conditions :
Growing aging populations and lifestyle-related factors in Rest Of Asia Pacific are driving demand for advanced urology diagnostic and treatment devices, supporting sustained market expansion.
Rest Of Asia Pacific Urology Devices Market Dynamics
- Emerging economies in the region are increasingly investing in modern medical infrastructure and diagnostic capabilities, creating significant opportunities for device manufacturers and healthcare providers.
- The 6.4% CAGR reflects strong demand for both diagnostic and therapeutic urology solutions. Key growth drivers include aging demographics, improving healthcare financing mechanisms, and growing adoption of minimally invasive procedures across the region.
- As healthcare systems modernize and disposable incomes rise, Rest Of Asia Pacific is expected to become an increasingly important market for urology device innovation and distribution.
- Strategic partnerships and localized product offerings will be critical for capturing market share in this dynamic region..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Rest Of Asia Pacific urology devices market valued at USD 2,107.9 million in 2025, expanding to USD 2,877.0 million by 2030
- Rest Of Asia Pacific exhibits a 6.4% CAGR, exceeding global growth rates and indicating strong regional momentum
- Rest Of Asia Pacific's growth is fueled by aging demographics, rising urological disease prevalence, and healthcare infrastructure improvements
- Rest Of Asia Pacific is increasingly adopting minimally invasive procedures and advanced diagnostic technologies in urology care
Urology Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | URINARY INCONTINENCE (UI) (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 34.57 (2025) |
| Revenue Forecast (Billions) | ~USD 46.26 (2030) |
| Segments Covered | Product, Type, Application, End User |
Rest Of Asia Pacific Urology Devices Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Consumables & Accessories
- Instruments
By Type
- Biopsy Devices
- Catheters
- Cystoscopes
- Dialysis Consumables
- Dialysis Devices
- Dilator Sets & Urethral Access Sheaths
- Drainage Bags
- Endoscopes
- Endoscopy Fluid Management Systems
- Endovision & Imaging Systems
- External Catheters
- Guidewires
- Hemodialysis Devices
- Indwelling/ Foley Catheters
- Insufflators
- Intermittent Catheters
- Laparoscopes
- Laser & Lithotripsy Devices
- Nephroscopes
- Other Consumables & Accessories
- Other Instruments
- Peritoneal Dialysis Devices
- Resectoscopes
- Retrieval Devices & Extractors
- Robotic Systems
- Stents And Implants
- Surgical Dissectors, Forceps & Needle Holders
- Tubes & Distal Attachments
- Ureteroscopes
- Urodynamic Systems
By Application
- Benign Prostatic Hyperplasia (Bph)
- Erectile Dysfunction
- Kidney Diseases
- Other Applications
- Pelvic Organ Prolapse
- Urinary Incontinence (Ui)
- Urinary Stones
- Urological Cancer
By End User
- Ambulatory Surgery Centers
- Clinics
- Dialysis Centers
- Home Care Settings
- Hospitals
Target Audience
- Medical Device Manufacturers : Manufacturers need Rest Of Asia Pacific-specific market data to identify growth opportunities, assess regional demand for urology devices, and develop localized product strategies for emerging markets.
- Healthcare Investors & PE Firms : Investment professionals require detailed regional market analysis to evaluate investment opportunities in Rest Of Asia Pacific healthcare infrastructure and urology device companies with strong growth potential.
- Hospital & Healthcare Facility Operators : Healthcare administrators need market insights to make informed procurement decisions, understand device adoption trends, and plan capital investments in urology departments across Rest Of Asia Pacific.
- Market Entry & Business Development Teams : Business development professionals need region-specific intelligence to assess market viability, identify distribution partners, and develop market entry strategies for Rest Of Asia Pacific operations.
- Healthcare Consultants & Analysts : Consultants require comprehensive Rest Of Asia Pacific market data to support client advisory work, competitive benchmarking, and strategic recommendations in the urology devices sector.
Key Companies in the Rest Of Asia Pacific Urology Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| SIEMENS HEALTHINEERS | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| NOVANTA, INC | United States | Public Company | Precision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration), |
| LUMENIS LTD | Israel | Private Company | Surgical,Ophthalmic,Aesthetic, |
| MERIT MEDICAL | United States | Public Company | Cardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits), |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Germany | Public Company | Care Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| B. BRAUN MELSUNGEN AG | Germany | Private Company | Infusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
| OLYMPUS CORPORATION | Japan | Public Company | Gastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions, |
| CARDINAL HEALTH | United States | Public Company | Branded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services, |
| INTUITIVE SURGICAL | United States | Public Company | da Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories, |
| COLOPLAST A/S | Denmark | Public Company | Ostomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel), |
| STRYKER | United States | Public Company | Orthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures), |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS), |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Advanced Wound Care,Ostomy Care,Continence Care, |
| MEDTRONIC PLC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
SIEMENS HEALTHINEERS
Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.
NOVANTA, INC
Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.
LUMENIS LTD
Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.
MERIT MEDICAL
Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.
FRESENIUS MEDICAL CARE AG & CO. KGAA
Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.
B. BRAUN MELSUNGEN AG
B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.
OLYMPUS CORPORATION
Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.
CARDINAL HEALTH
Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.
INTUITIVE SURGICAL
Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.
COLOPLAST A/S
Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.
STRYKER
Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.
TELEFLEX INCORPORATED
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.
CONVATEC GROUP PLC
ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.
MEDTRONIC PLC
Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.
Reasons to Buy this Report
- Regional Market Sizing & Forecasting : Obtain precise market valuations specific to Rest Of Asia Pacific (USD 2,107.9M in 2025, USD 2,877.0M in 2030) with detailed 5-year projections to support strategic planning and investment decisions.
- Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within Rest Of Asia Pacific to identify partnership opportunities and market entry strategies tailored to regional conditions.
- Growth Driver Analysis : Gain insights into region-specific factors driving the 6.4% CAGR, including healthcare investments, demographic trends, and regulatory environments across Rest Of Asia Pacific countries.
- Emerging Market Opportunity Assessment : Evaluate high-potential segments and underserved markets within Rest Of Asia Pacific to prioritize resource allocation and develop targeted go-to-market strategies for maximum ROI.
- Strategic Decision Support : Access comprehensive regional data to inform product development, market expansion, pricing strategies, and partnership decisions specific to Rest Of Asia Pacific's unique healthcare landscape.
Frequently asked questions
What is the current market size of urology devices in Rest Of Asia Pacific?
Rest Of Asia Pacific's urology devices market is valued at USD 2,107.9 million in 2025 and is expected to reach USD 2,877.0 million by 2030.
What is the projected growth rate for Rest Of Asia Pacific urology devices market?
Rest Of Asia Pacific's urology devices market is projected to grow at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2030.
What factors are driving growth in Rest Of Asia Pacific's urology devices market?
Rest Of Asia Pacific's market growth is driven by aging populations, increasing prevalence of urological disorders, improving healthcare infrastructure, and rising adoption of minimally invasive procedures.
How does Rest Of Asia Pacific's growth compare to the global urology devices market?
Rest Of Asia Pacific's 6.4% CAGR exceeds the global market CAGR of 6%, demonstrating stronger regional growth momentum and market potential.
What types of urology devices are in demand in Rest Of Asia Pacific?
Rest Of Asia Pacific shows increasing demand for diagnostic devices, minimally invasive surgical instruments, urinary catheters, and advanced treatment technologies for benign prostatic hyperplasia and urinary incontinence.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Urology Devices Market : Top-Down and Bottom-Up Approach
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.
Key Stakeholders
- Manufacturers and Distributors of Urology Devices
- Hospitals and ASCs
- Academic Research Institutes
- Urology Clinics
- Urology Device Service Providers
- Venture Capitalists and Investors
- Clinical Research Organizations (CROs)
Report Objectives
- To define, describe, and forecast the urology devices market by product, application, end user, and region
- To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall urology devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as product launches, product approvals, mergers, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
- To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market
Customization Options
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix gives a detailed comparison of the product portfolios of the top five companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Geographical Analysis
- A further breakdown of the Rest of Europe’s urology devices market into countries
- A further breakdown of the Rest of Asia Pacific’s urology devices market into countries
- A further breakdown of Latin America’s urology devices market into countries
Get the Full Urology Devices Market Report
Full forecast, segment splits, and company analysis for all Urology Devices Market.
- US Urology Devices Market
- Canada Urology Devices Market
- Germany Urology Devices Market
- UK Urology Devices Market
- France Urology Devices Market
- Italy Urology Devices Market
- Spain Urology Devices Market
- China Urology Devices Market
- Japan Urology Devices Market
- India Urology Devices Market
- Brazil Urology Devices Market
- Mexico Urology Devices Market
- Rest Of Europe Urology Devices Market
- Rest Of Latin America Urology Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report